Gene Therapy Progress and Prospects: Recombinant adeno-associated virus (rAAV) vectors
Open Access
- 25 March 2004
- journal article
- review article
- Published by Springer Nature in Gene Therapy
- Vol. 11 (10) , 805-810
- https://doi.org/10.1038/sj.gt.3302233
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapyBlood, 2003
- Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liverGene Therapy, 2003
- Identification of Amino Acid Residues in the Capsid Proteins of Adeno-Associated Virus Type 2 That Contribute to Heparan Sulfate Proteoglycan BindingJournal of Virology, 2003
- Adeno-associated viruses undergo substantial evolution in primates during natural infectionsProceedings of the National Academy of Sciences, 2003
- The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapyProceedings of the National Academy of Sciences, 2002
- Adeno-Associated Virus Serotype 4 (AAV4) and AAV5 Both Require Sialic Acid Binding for Hemagglutination and Efficient Transduction but Differ in Sialic Acid Linkage SpecificityJournal of Virology, 2001
- Several Log Increase in Therapeutic Transgene Delivery by Distinct Adeno-Associated Viral Serotype VectorsMolecular Therapy, 2000
- Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered TropismJournal of Virology, 2000
- Novel Transcriptional Regulatory Signals in the Adeno-Associated Virus Terminal Repeat A/D Junction ElementJournal of Virology, 2000
- Adeno-Associated Virus Type 5 (AAV5) but Not AAV2 Binds to the Apical Surfaces of Airway Epithelia and Facilitates Gene TransferJournal of Virology, 2000